Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Capital Employed (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has disclosed Return on Capital Employed for 5 consecutive years, with 0.32% as the latest value for Q4 2020.

  • For Q4 2020, Return on Capital Employed rose 79.0% year-over-year to 0.32%; the TTM value through Dec 2020 reached 0.32%, up 79.0%, while the annual FY2025 figure was 0.54%, 6.0% up from the prior year.
  • Return on Capital Employed hit 0.32% in Q4 2020 for Syndax Pharmaceuticals, up from 0.39% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.22% in Q2 2016 and bottomed at 1.12% in Q4 2019.
  • Average Return on Capital Employed over 5 years is 0.63%, with a median of 0.53% recorded in 2017.
  • Year-over-year, Return on Capital Employed crashed -49bps in 2018 and then surged 79bps in 2020.
  • Syndax Pharmaceuticals' Return on Capital Employed stood at 0.42% in 2016, then fell by -27bps to 0.54% in 2017, then plummeted by -90bps to 1.02% in 2018, then decreased by -9bps to 1.12% in 2019, then surged by 71bps to 0.32% in 2020.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.32%, 0.39%, and 0.43% for Q4 2020, Q3 2020, and Q2 2020 respectively.